Hyperliquid Labs Begins Unstaking $320 Million in HYPE Tokens for OTC Deal
The entire tranche is intended to be used for an over-the-counter, or OTC, purchase involving an institutional player, BSCN reported, citing internal communication shared on Discord.
$320 Million HYPE Tranche Set for OTC Purchase
The unstaking involves HYPE tokens allocated under Hyperliquid’s planned monthly release for the core team. Rather than being directed toward open-market trading, the full tranche is reportedly intended for an OTC transaction.
OTC transactions are conducted directly between counterparties rather than through a public exchange order book. In this case, BSCN reported that the planned transaction involves an institutional player, although the post did not identify the institution involved.
The reported $320 million figure represents the value of the HYPE tokens in the tranche cited by BSCN. The source did not provide the number of HYPE tokens being unstaked or specify the price used to calculate the stated value.
Hyperliquid’s Monthly Core Team Release
The unstaking is part of Hyperliquid Labs’ planned monthly core team token release, according to the report. The timing therefore falls within an existing release mechanism rather than representing a separately announced token allocation.
BSCN cited internal communication on Discord as the source for the information about how the tranche is intended to be used. The communication reportedly states that the entire amount will be allocated to the OTC purchase.
The identity of the institutional buyer was not disclosed in the source material. No additional details were provided regarding the transaction’s execution date, settlement terms or the price agreed between the parties.
Institutional Transaction Remains the Stated Use
The reported transaction is notable for the stated destination of the unstaked tokens: an institutional OTC purchase rather than general market distribution.
Because the source describes the arrangement as an OTC transaction, the reported deal is separate from activity conducted through public exchange order books. However, BSCN did not provide details that would establish the identity of the counterparty or the final terms of the transaction.
For now, the available information indicates that Hyperliquid Labs has begun unstaking the $320 million HYPE tranche as part of its monthly core team release, with the full amount intended for an OTC purchase involving an institutional player.
Writer: Ethan Collins
Crypto Journalist
Ethan Collins reports on developments across the cryptocurrency and blockchain sector. His work covers market movements, protocol updates, regulatory changes, and emerging trends in digital assets.
He focuses on presenting complex topics in a clear and accessible manner for a broad readership.
Check out other news and articles on Google News
Disclaimer:
The articles on Hokanews are here to keep you updated on the latest buzz in crypto, tech, and beyond—but they’re not financial advice. We’re sharing info, trends, and insights, not telling you to buy, sell, or invest. Always do your own homework before making any money moves.
Hokanews isn’t responsible for any losses, gains, or chaos that might happen if you act on what you read here. Investment decisions should come from your own research—and, ideally, guidance from a qualified financial advisor. Remember: crypto and tech move fast, info changes in a blink, and while we aim for accuracy, we can’t promise it’s 100% complete or up-to-date.